Impact of Protease Inhibitor-Based Antiretroviral Therapy on Tacrolimus Intrapatient Variability in HIV-Positive Kidney Transplant Recipients

被引:9
|
作者
Cooper, Megan [1 ]
Dunne, Ian [1 ]
Kuten, Samantha [1 ]
Curtis, Anna [1 ]
Graviss, Edward A. [2 ]
Nguyen, Duc T. [2 ]
Hobeika, Mark [3 ]
Gaber, A. Osama [3 ]
机构
[1] Houston Methodist Hosp, Dept Pharm, Houston, TX 77030 USA
[2] Houston Methodist Res Inst, Dept Pathol & Genom Med, Houston, TX USA
[3] Houston Methodist Hosp, Dept Surg, Houston, TX 77030 USA
关键词
INFECTED PATIENTS; OUTCOMES; REGIMEN; RISK;
D O I
10.1016/j.transproceed.2020.10.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Human immunodeficiency virus (HIV)-positive kidney transplant (KT) recipients have been shown to experience higher rejection rates due in part to drug-drug interactions between antiretroviral therapy (ART) and immunosuppression regimens. High tacrolimus (FK) intrapatient variability (IPV) is associated with inferior outcomes in KT. The purpose of this study was to determine the impact of protease inhibitor (PI)-based ART on FK IPV and graft outcomes. Methods. We performed a single-center review of HIV-positive KT recipients from 2007 to 2017. Percentage coefficient of variation (%CV =(sigma/mu) x 100; sigma, median; m, standard deviation) was calculated for FK IPV. FK IPV at 6 and 12 months, graft function, and immune outcomes in PI-based vs non-PI-based KT recipients were compared. Results. A total of 23 HIV-positive KT patients were identified, of whom 10 were maintained on PI-based ART. Median IPV for the entire cohort at 6 and 12 months was 35.8% and 41%, respectively. Patients on PI-based regimens were proportionally more likely to experience high IPV at both time points. Median FK IPV was numerically higher at 6 months (37.3% vs 26.8%, P = .11) and significantly higher at 12 months (57.8% vs 30.9%, P = .01) for patients on PI-based regimens. Lastly, inferior graft function was observed in PI-based patients. Conclusion. Our data suggest that PI-based ART is associated with a higher degree of FK IPV, which may contribute to worsening graft function. Larger studies are warranted to determine the impact of PI-based ART on FK IPV and graft outcomes in this population.
引用
收藏
页码:984 / 988
页数:5
相关论文
共 49 条
  • [41] Dyslipidemia among HIV-infected Patients with Tuberculosis Taking Once-daily Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in India
    Padmapriyadarsini, Chandrasekaran
    Kumar, S. Ramesh
    Terrin, Norma
    Narendran, Gopalan
    Menon, Pradeep A.
    Ramachandran, Geetha
    Subramanyan, Sudha
    Venkatesan, Perumal
    Wanke, Christine
    Swaminathan, Soumya
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (04) : 540 - 546
  • [42] EFFICACY OF NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR-BASED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN THAI HIV-INFECTED CHILDREN AGED TWO YEARS OR LESS
    Puthanakit, Thanyawee
    Aurpibul, Linda
    Sirisanthana, Thira
    Sirisanthana, Virat
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2009, 28 (03) : 246 - 248
  • [43] Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis
    Saint-Lary, Laura
    Benevent, Justine
    Damase-Michel, Christine
    Vayssiere, Christophe
    Leroy, Valeriane
    Sommet, Agnes
    BMC PREGNANCY AND CHILDBIRTH, 2023, 23 (01)
  • [44] Prevalence of peripheral neuropathy in antiretroviral therapy naive HIV-positive patients and the impact on treatment outcomes - a retrospective study from a large urban cohort in Johannesburg, South Africa
    Evans, Denise
    Takuva, Simbarashe
    Rassool, Mohammed
    Firnhaber, Cindy
    Maskew, Mhairi
    JOURNAL OF NEUROVIROLOGY, 2012, 18 (03) : 162 - 171
  • [45] Impact of intra-patient variability of tacrolimus on allograft function and CD4+/CD8+ratio in kidney transplant recipients: a retrospective single-center study
    Wang, Xuebin
    Liu, Zhengyue
    Chen, Jingxia
    Chai, Yuhui
    Shao, Xueqing
    Xie, Wenmin
    Zheng, Kaile
    You, Jia
    Wang, Zhuo
    Feng, Meiqing
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2024, 46 (04) : 918 - 925
  • [46] Rifaximin has a Marginal Impact on Microbial Translocation, T-cell Activation and Inflammation in HIV-Positive Immune Non-responders to Antiretroviral Therapy - ACTG A5286
    Tenorio, Allan R.
    Chan, Ellen S.
    Bosch, Ronald J.
    Macatangay, Bernard J. C.
    Read, Sarah W.
    Yesmin, Suria
    Taiwo, Babafemi
    Margolis, David M.
    Jacobson, Jeffrey M.
    Landay, Alan L.
    Wilson, Cara C.
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 (05): : 780 - 790
  • [47] Ten-year attrition and antiretroviral therapy response among HIV-positive adults: a sex-based cohort analysis from eight West African countries
    Tiendrebeogo, Thierry
    Messou, Eugene
    Arikawa, Shino
    Ekouevi, Didier K.
    Tanon, Aristophane
    Kwaghe, Vivian
    Balestre, Eric
    Zannou, Marcel Djimon
    Poda, Armel
    Dabis, Francois
    Jaquet, Antoine
    Minga, Albert
    Becquet, Renaud
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 (05)
  • [48] Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy
    Lange, Camille Marie
    Hue, Stephane
    Violari, Avy
    Cotton, Mark
    Gibb, Diana
    Babiker, Abdel
    Otwombe, Kennedy
    Panchia, Ravindre
    Dobbels, Els
    Jean-Philippe, Patrick
    McIntyre, James A.
    Pillay, Deenan
    Gupta, Ravindra Kumar
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 69 (02) : 138 - 144
  • [49] Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study
    Caniglia, Ellen C.
    Cain, Lauren E.
    Sabin, Caroline A.
    Robins, James M.
    Logan, Roger
    Abgrall, Sophie
    Mugavero, Michael J.
    Hernandez-Diaz, Sonia
    Meyer, Laurence
    Seng, Remonie
    Drozd, Daniel R.
    Seage, George R., III
    Bonnet, Fabrice
    Dabis, Francois
    Moore, Richard D.
    Reiss, Peter
    van Sighem, Ard
    Mathews, William C.
    del Amo, Julia
    Moreno, Santiago
    Deeks, Steven G.
    Muga, Roberto
    Boswell, Stephen L.
    Ferrer, Elena
    Eron, Joseph J.
    Napravnik, Sonia
    Jose, Sophie
    Phillips, Andrew
    Justice, Amy C.
    Tate, Janet P.
    Gill, John
    Pacheco, Antonio
    Veloso, Valdilea G.
    Bucher, Heiner C.
    Egger, Matthias
    Furrer, Hansjakob
    Porter, Kholoud
    Touloumi, Giota
    Crane, Heidi
    Miro, Jose M.
    Sterne, Jonathan A.
    Costagliola, Dominique
    Saag, Michael
    Hernan, Miguel A.
    LANCET HIV, 2017, 4 (06): : E251 - E259